title: Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients.
authors.forename: Miranda
authors.initials: M
authors.lastname: Athanassiou-Metaxa
authors.forename: Aphroditi
authors.initials: A
authors.lastname: Kousi
authors.forename: Emmanouil S
authors.initials: ES
authors.lastname: Hatzipantelis
authors.forename: Ioanna
authors.initials: I
authors.lastname: Tsatra
authors.forename: Marina
authors.initials: M
authors.lastname: Ikonomou
authors.forename: V
authors.initials: V
authors.lastname: Perifanis
authors.forename: Haido
authors.initials: H
authors.lastname: Tsantali
mesh_terms: D000293:Adolescent; D000328:Adult; D015913:Chelation Therapy / Q000009:adverse effects / Q000379:methods*; D000077543:Deferiprone; D003676:Deferoxamine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005293:Ferritins / Q000097:blood; D006720:Homozygote; D006801:Humans; D019190:Iron Overload / Q000188:drug therapy; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000628:therapy
chemical_list: D011728:Pyridones; D000077543:Deferiprone; D005293:Ferritins; D003676:Deferoxamine